IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 202 filers reported holding IMMUNOGEN INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $437,000 | +41.9% | 85,660 | -32.7% | 0.02% | +66.7% |
| Q3 2019 | $308,000 | -35.0% | 127,305 | +154.6% | 0.02% | +7.1% |
| Q3 2018 | $474,000 | -90.7% | 50,006 | -90.5% | 0.01% | -91.1% |
| Q2 2018 | $5,124,000 | -3.3% | 526,660 | +4.5% | 0.16% | -7.1% |
| Q1 2018 | $5,300,000 | +69.1% | 503,765 | +3.0% | 0.17% | +76.0% |
| Q4 2017 | $3,135,000 | -16.5% | 489,035 | -0.3% | 0.10% | -19.3% |
| Q3 2017 | $3,753,000 | +141.8% | 490,635 | +124.7% | 0.12% | +183.3% |
| Q2 2017 | $1,552,000 | – | 218,320 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |